pharmacia Corporation Patents : |
| US Patent No. | Title |
| 7208490 | Tricyclic tetrahydroquinoline antibacterial agents
|
| 7244755 | Hydroxypropylamines
|
| 7247627 | Salts and polymorphs of a pyrrole-substituted indolinone compound
|
| 7247706 | Double mutant alpha-7 nicotinic acetylcholine receptors
|
| 7256189 | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
|
| 7259266 | Benzopyran compounds useful for treating inflammatory conditions
|
| 7262208 | Hydroxypropyl amides for the treatment of Alzheimer's disease
|
| 7276503 | Method of treating chronic fatigue syndrome
|
| 7291738 | Therapeutic compounds
|
| 7309811 | Transgenic mice knockouts of BACE-1
|
| 7312333 | Retroviral protease inhibitors
|
| 7244725 | Acetyl 2-hydroxy-1, 3-diaminoalkanes
|
| 7241762 | Method of treating peripheral neuropathy
|
| 7208591 | G protein-coupled receptor-like receptors and modulators thereof
|
| 7211686 | Process for making optically active .alpha.-amino ketones and selected novel optically active .alpha.-amino ketones
|
| 7214715 | Compounds to treat Alzheimer's disease
|
| 7220434 | Dual-release compositions of a cyclooxygenase-2 inhibitor
|
| 7220867 | Solid-state form of celecoxib having enhanced bioavailability
|
| 7229965 | Use of growth hormone in low dose
|
| 7232894 | Method for the production of recombinant peptides with a low amount of trisulfides
|
| 7232930 | Compounds and methods for preparing methanesulfonamides
|
| 7235655 | Processes to prepare eplerenone
|
| 7238507 | Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
|
| 7312360 | Substituted hydroxyethylamines
|
| 7317011 | Method of treating peripheral neuropathy
|
| 7320996 | Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer
|
| 7420061 | Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
|
| 7435832 | Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
|
| 7442691 | Macrocycles useful in the treatment of alzheimer's disease
|
| 7445641 | Biomaterials modified with superoxide dismutase mimics
|
| 7452913 | Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
|
| 7456269 | Alzheimer's disease secretase, APP substrates thereof, and uses thereof
|
| 7476391 | Anti-bacterial vaccine compositions
|
| 7498436 | Substituted hydroxyethylamines
|
| 7572924 | Pyrrole substituted 2-indolinone protein kinase inhibitors
|
| 7582756 | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
|
| 7378511 | Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
| 7377894 | Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules
|
| 7322965 | Infection-resistant medical devices
|
| 7338953 | Method of treating chronic fatigue syndrome
|
| 7338965 | 3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines
|
| 7351738 | Substituted ureas and carbamates
|
| 7354724 | Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
| 7354943 | Statine derivatives for the treatment of Alzheimer's disease
|
| 7358264 | Statine derivatives for the treatment of Alzheimer's disease
|
| 7364866 | Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
| 7368536 | Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
| 7375187 | Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
| 7605157 | Tricyclic tetrahydroquinoline antibacterial agents
|
